BNT162b2 Aşısı Sonrası Gelişen İmmün Aracılı Trombotik Trombositopenik Purpura
Tekin Guney1, Ferda Can1, Sema Akıncı1, Özge Soyer Kösemehmetoğlu1, İmdat Dilek21University of Health Sciences Turkey, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey2Yıldırım Beyazıt University, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey
Anahtar Kelimeler: COVİD-19 aşı, Trombotik trombositopenik purpura, BNT162b2
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
Tekin Guney1, Ferda Can1, Sema Akıncı1, Özge Soyer Kösemehmetoğlu1, İmdat Dilek21University of Health Sciences Turkey, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey2Yıldırım Beyazıt University, Ankara City Hospital, Clinic of Hematology, Ankara, Turkey
Keywords: COVID-19 vaccine, Thrombotic thrombocytopenic purpura, BNT162b2
Tekin Guney, Ferda Can, Sema Akıncı, Özge Soyer Kösemehmetoğlu, İmdat Dilek. Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine. . 2022; 39(1): 74-75
Sorumlu Yazar: Ferda Can, Türkiye
Sorumlu Yazar: Ferda Can, Türkiye
| ARAÇLAR |
 Tam Metin PDF Yazdır Alıntıyı İndir RIS EndNote BibTex Medlars Procite Reference Manager E-Postala Paylaş Yazara e-posta gönder
Benzer makaleler Google Scholar |